Podiatry Billing 2026: Routine Foot Care Under the New MVP

Podiatry Billing 2026: Routine Foot Care Under the New MVP

CMS introduced a dedicated MIPS Value Pathway for podiatry beginning with the 2026 reporting year, the first specialty-specific MVP for foot and ankle care. At the same time, OIG continues to flag routine foot care billing as a high-error audit lane, particularly around the use of Q7, Q8, and Q9 modifiers and the supporting class findings documentation. For podiatry practices, 2026 is the year both quality reporting and audit-readiness on routine care need to align, because failing on either front affects reimbursement directly.

What the podiatry MVP requires

The Value in Podiatry MVP bundles quality measures, improvement activities, and promoting interoperability metrics that are clinically relevant to podiatry. Quality measures include screenings and management of diabetic foot ulcers, peripheral neuropathy assessment, fall risk assessment in elderly patients, and appropriate antibiotic prescribing for foot and ankle infections. Practices reporting MVP have a clearer pathway to MIPS positive adjustments than those still reporting through the traditional MIPS framework, and the data submission deadlines align with the calendar year. Practices that have not yet engaged with MIPS at all should treat the MVP as the entry point in 2026.

Routine foot care: the audit fundamentals

Medicare generally does not cover routine foot care (cutting nails, trimming corns and calluses, removing dead skin) for asymptomatic patients without systemic conditions. Coverage is available when the patient has a systemic condition that puts foot care at risk if performed by a non-professional, including peripheral vascular disease, diabetes mellitus with neurological or vascular complications, severe rheumatoid arthritis, and others. Documentation must establish the qualifying condition, demonstrate class findings appropriate to the condition, and tie the foot care service to the medical necessity created by that condition.

Q7, Q8, and Q9 modifiers and class findings

Modifiers Q7, Q8, and Q9 indicate the level of class findings supporting routine foot care. Q7 means one Class A finding (non-traumatic amputation, absent posterior tibial pulse, or others). Q8 means two Class B findings (advanced trophic changes including hair loss, nail changes, pigmentary changes, skin texture changes). Q9 means one Class B finding plus two Class C findings (claudication, temperature changes, edema, paresthesia, burning). The most common audit failure is documentation that uses the modifier without listing the specific findings observed during the encounter. The defense is a structured exam template that prompts the provider to document each finding by class.

Diabetic patients and the LCD requirements

For diabetic patients, Medicare typically requires that the certifying or treating physician for the diabetes (often the primary care physician) is also seeing the patient for diabetes management within a defined window, usually six months. The podiatrist’s documentation should reference that physician by name, the date of the most recent diabetes visit, and the specific diabetic complication that justifies podiatric care. LCD requirements vary by Medicare Administrative Contractor, so practices should check their MAC’s published LCD for routine foot care and align documentation to it.

Beyond routine: nail debridement and ulcer care

Nail debridement (CPT 11720, 11721) is not the same as routine nail trimming and has different coverage rules. Coverage requires mycotic nails with documented pain or significant impairment of ambulation. Documentation must include the involved nails, the clinical findings supporting mycotic involvement (lab confirmation is not always required, but the clinical picture should be specific), and the patient’s symptomatic limitation. Diabetic foot ulcer care, debridement (CPT 11042 through 11047), and selective debridement codes have their own audit profiles and require depth-of-tissue documentation that aligns with the code billed.

Frequency limits

Medicare imposes frequency limits on most routine foot care services, typically once every 60 days. Claims billed inside the 60-day window deny under CARC 119 (benefit maximum reached for time period) unless the practice can document a clinical change that justifies more frequent care. The defense is calendaring the next eligible date at the time of each visit and scheduling accordingly. Practices that book on patient request without checking the prior date frequently submit claims that deny on a frequency rule, which then become collection problems.

How MHB helps podiatry practices

For podiatry practices that want specialty-trained coders working their claims with MAC-specific LCD knowledge, class-findings audit support, frequency-rule tracking, and MVP reporting alignment, our team handles end-to-end medical coding for podiatry. The work integrates with the practice’s existing EHR.

The bottom line

Podiatry billing in 2026 has two new pressures: a specialty-specific MVP that ties quality reporting to reimbursement, and continued OIG focus on routine foot care. Both pressures reward documentation discipline at the time of the encounter. Class findings entered with structure, MAC LCDs aligned to the practice’s documentation, and frequency rules built into scheduling are the difference between revenue captured and revenue lost.

Share

Written by the MHB Editorial Team

The revenue cycle and medical billing specialists at My Healthcare Billing. We work with 2,000+ practices across 75+ specialties and write about what actually moves the needle on collections, denials, and coding accuracy.

Keep reading

More on Industry Trends

Free, no-obligation

See what your practice is leaving on the table.

30-minute free billing audit. We'll surface the leaks (undercoding, denials never appealed, eligibility errors) and quantify the dollars you can recover this quarter.

What you get

  • A line-by-line review of your last 90 days of claims
  • Specialty benchmark on clean-claim ratio & days in A/R
  • Written estimate of recoverable revenue this quarter
  • Zero pressure. Zero commitment.